Deliberato named chief research information officer at the UC College of Medicine

Brings international reputation for critical care, immunology and machine learning

Rodrigo Deliberato, MD, PhD, has been appointed chief research information officer for the University of Cincinnati College of Medicine and UC Physicians. He also serves as professor in the college’s Department of Biomedical Informatics.

Deliberato previously served for the last four years as the vice president of research and translational medicine at Endpoint Health in Palo Alto, California, where he led an interdisciplinary research team focused on building data-driven precision immunology solutions, aiming to identify homogenous biological subgroups of patients with complex heterogenous immunological disorders to potentially translate cutting-edge research into personalized therapies to meet each patient's unique clinical needs.

“Dr. Deliberato’s recruitment is an essential addition to the college and the UC Family. This position involves more effort in applying for research grants and will deepen connections with other resources involving data and analytics. His leadership will help us improve our research and ultimately benefit patients and students at every level,” says Umberto Tachinardi, MD, associate dean of health informatics, interim chair and professor, Department of Biomedical Informatics, and senior vice president and chief health digital officer, UC Health.

Rodrigo Deliberato   Biomedical Informatics

Rodrigo Deliberato, MD, PhD (Photo/Dan Davenport)

At the College of Medicine, Deliberato will leverage his expertise in advanced data and analytics (machine learning and AI) leading the advancement of informatics solutions to enhance clinical research, data repositories and streamline processes to enhance the effective utilization of electronic health record (EHR) data, constructing frameworks to support advanced data analysis, bioinformatics and precision medicine investigations, all while balancing the need for data security and privacy.

Deliberato's appointment, facilitated by the collaboration between the Cincinnati Children’s Division of Biomedical Informatics, UC Digital Futures and UC-Health, is a significant step in fostering stronger ties among Cincinnati's leading clinical and biomedical research entities, Tachinardi says. This joint effort highlights a unified goal to advance medical research and health care, leveraging Deliberato’s expertise and the combined strengths of these organizations. “The move signals an optimistic future characterized by innovation and deeper collaboration in the region's biomedical landscape,” Tachinardi adds.

Deliberato has an extensive background in medicine spanning four countries: Brazil, the United Kingdom, Canada and the United States. Deliberato has earned an international reputation for his contributions to critical care, immunology and machine learning. He has published numerous peer-reviewed articles and has played an instrumental role in groundbreaking projects, notably, leading the creation of the first hospital-wide patient-level research database in South America which provided broader access to valuable data. He also developed a multi-platform clinician scheduling system that currently has in excess of 130,000 users across more than 100 hospitals and manages 3 million shifts.

“Deliberato is an expert in building and leading interdisciplinary research teams, leveraging advanced machine-learning techniques to extract insights from high-dimensional molecular and clinical data. His vast experience as a research scientist will complement our tripartite mission of research, teaching, and clinical care. We are very excited to have Dr. Deliberato joining us. His expertise and collaborative spirit will, without a doubt, enhance our data-driven culture,” Tachinardi says.

Deliberato received his medical degree in 2004 from Universidad de Mogi das Cruzes in Brazil. He is board board-certified in Brazil in internal medicine and critical care and is a former Critical Care Clinical Fellow at the University of Toronto. He holds a master’s and a doctoral degree in infectious disease from the Federal University of São Paulo and completed a postdoctoral fellowship in data science at the Massachusetts Institute of Technology.

Related Stories


UC COVID-19 studies awarded $425K

April 15, 2020

Understanding that time was of the essence in combating this highly infectious disease, UC and its College of Medicine’s Office of Research conducted a rapid review and distribution of $425,000 in novel pilot grants to researchers, focusing on eradicating the disease.


A potential new treatment for brain tumors

September 23, 2022

The University of Cincinnati's Pankaj Desai, PhD, has received a $1.19 million grant from the National Institutes of Health/National Institute of Neurological Disorders and Stroke to continue research into the use of a drug called letrozole to treat glioblastomas, the most deadly form of brain tumors.